These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5158102)

  • 21. [A technic of preparation of an intestinal loop in the rat for the study ofjejunal dialysis in the treatment of uremia].
    Hamburger J; Donovski L; Marche C
    Pathol Biol (Paris); 1970 Apr; 18(7):403-6. PubMed ID: 4911092
    [No Abstract]   [Full Text] [Related]  

  • 22. The creatine kinase profile of a maintenance hemodialysis population: a possible marker of uremic myopathy.
    Cohen IM; Griffiths J; Stone RA; Leech T
    Clin Nephrol; 1980 May; 13(5):235-8. PubMed ID: 7398146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodiafiltration using a hybrid membrane system for self-generation of diluting fluid.
    Cheung AC; Kato Y; Leypoldt JK; Henderson LW
    Trans Am Soc Artif Intern Organs; 1982; 28():61-5. PubMed ID: 7164312
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum levels of medium-sized molecules in children with chronic kidney failure under conditions of short-term hemodialysis].
    Scigalla P; Gudim VI; Noack C; Devaux S; Grossmann P
    Z Urol Nephrol; 1980 Dec; 73(12):915-22. PubMed ID: 7223091
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of more than 6 months of hemodialytic treatment with a new type of adsorbent membrane].
    Giorcelli G; Linari F; Marangella F; Bajardi P; Vacha G; Zaffino MC
    Minerva Nefrol; 1979; 26(2):189-90. PubMed ID: 471348
    [No Abstract]   [Full Text] [Related]  

  • 27. Glomerular and tubular factors in the genesis of post-ischaemic renal failure.
    Bálint P; Tabara I; Visy M
    Acta Physiol Acad Sci Hung; 1967; 31(3):235-42. PubMed ID: 6030731
    [No Abstract]   [Full Text] [Related]  

  • 28. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
    Jørstad S; Smeby LC; Widerøe TE; Berg KJ
    Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microcapsule artificial kidney: including updated preparative procedures and properties.
    Chang TM
    Kidney Int Suppl; 1976 Dec; (7):S218-24. PubMed ID: 1070536
    [No Abstract]   [Full Text] [Related]  

  • 31. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemofiltration in uremia: clinical approach].
    Vantelon J; Lauriat F; Perrone B; Jeannot F
    J Urol Nephrol (Paris); 1977 Sep; 83(9):712-7. PubMed ID: 926235
    [No Abstract]   [Full Text] [Related]  

  • 33. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
    Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
    Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
    [No Abstract]   [Full Text] [Related]  

  • 34. [A dialysis system with regeneration and recirculation of the dialyzing fluid. In vitro tests of the regeneration of the dialyzing fluid of the artificial kidney and the peritoneal dialysis].
    Jutzler GA
    Ann Univ Sarav Med; 1968; 15(1):1-127. PubMed ID: 5713077
    [No Abstract]   [Full Text] [Related]  

  • 35. [First experiences with the cuprophane coil ExO1].
    Schmidt P; Mayrhofer E; Kotzaurek R
    Wien Med Wochenschr; 1969 May; 119(22):409-11. PubMed ID: 5801628
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of reduced protein diets on morbidity, mortality, and renal function in dogs with induced chronic renal failure.
    Polzin DJ; Osborne CA; Hayden DW; Stevens JB
    Am J Vet Res; 1984 Mar; 45(3):506-17. PubMed ID: 6711979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of low clearances of small solutes during peritoneal dialysis.
    Nolph KD; Popovich RP; Ghods AJ; Twardowski Z
    Kidney Int; 1978 Feb; 13(2):117-23. PubMed ID: 713273
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic kidney failure: problems of pathogenesis and treatment].
    Ermolenko VM
    Ter Arkh; 1982; 54(7):114-8. PubMed ID: 6753210
    [No Abstract]   [Full Text] [Related]  

  • 39. Low volume bag-filter dialysis: a simplified technique for treatment of uremic patients.
    Bazzato G; Coli U; Landini S; Fracasso A; Morachiello P; Righetto F; Scanferla F
    Semin Nephrol; 1986 Jun; 6(2):153-60. PubMed ID: 3616228
    [No Abstract]   [Full Text] [Related]  

  • 40. Membranes for blood purification: state of the art and new developments.
    Strathmann H; Göhl H
    Contrib Nephrol; 1990; 78():119-40; discussion 140-1. PubMed ID: 2225829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.